Neurogenic overactive bladder in spinal cord injury and multiple sclerosis: role of onabotulinumtoxinA
KD Ethans, AR Casey, RJ Bard… - Degenerative …, 2014 - Taylor & Francis
People with neurogenic overactive bladder from either multiple sclerosis or spinal cord
injury often suffer significant morbidity and decreased quality of life. Here we review the …
injury often suffer significant morbidity and decreased quality of life. Here we review the …
Onabotulinum toxin A: a therapeutic option for refractory neurogenic detrusor overactivity and idiopathic overactive bladder.
P Ellsworth, M Travis - Urologic Nursing, 2014 - search.ebscohost.com
Overactive bladder syndrome affects up to 17% of the American population and adversely
impacts quality of life. Antimuscarinic agents have been the primary treatment of neurogenic …
impacts quality of life. Antimuscarinic agents have been the primary treatment of neurogenic …
[PDF][PDF] Monitorace ztráty botulinuMtoxinu při aplikaci do detruzoru–výsledky pilotní fáze studie
V Šámal, J Műllerová, V Paldus, J Mečl… - Česká urologie, 2014 - czechurol.cz
Monitorace ztráty botulinuMtoxinu při aplikaci do detruzoru – výsledky pilotní fáze studie Page
1 strana 33 Ces Urol 2014; 18(1): 33–39 původní práce Monitoring the loss of botulinuM toxin …
1 strana 33 Ces Urol 2014; 18(1): 33–39 původní práce Monitoring the loss of botulinuM toxin …